Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
Int J Hematol
; 117(3): 463-467, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-36202948
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Plasmacytoma
/
POEMS Syndrome
/
Hematopoietic Stem Cell Transplantation
Type of study:
Prognostic_studies
Limits:
Humans
/
Male
Language:
En
Journal:
Int J Hematol
Journal subject:
HEMATOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Japan
Country of publication:
Japan